International Journal of Cancer · 1999 · 17 citations · 20 references
Life SciencesImmunologyInfectious DiseasesMolecular VirologySpatial EpidemiologyVirologyHiv EpidemiologyViral EpidemiologyViral HepatitisViral InfectionsHuman T-lymphotropic Virus ScreeningIndividual ResidenceInfection Risk FactorsLogistic RegressionLogistic Regression AnalysisTransmission Risk FactorsViral Serology Screening
Between January 1989 and December 1996, 59,426 blood donors from Guadeloupe (French West Indies) were screened for antibodies to human T-cell lymphotropic virus type I (HTLV-I). Of these, 195 were confirmed as being positive for HTLV-I, yielding an overall prevalence of 0.33% [95% confidence interval (CI) 0.28-0.38]. On multiple logistic regression analysis, risk factors for HTLV-I were female gender [odds ratio (OR) 1.8; CI 1.3-2.4], increasing age (30-39 years, OR 2.2, CI 1.4-3.4; 40-49 years, OR 3.1, CI 2.1-4.7; > or =50 years, OR 5.6, CI 3.6-8.6) and positive hepatitis B core antibodies (OR 2.0; CI 1.5-2.8). HTLV-I seropositivity was also significantly associated with current residence in certain areas, highlighting microgeographic clustering: individuals living along the Atlantic Facade of Guadeloupe, which is a traditional sugar cane plantation area where Africans were brought during slave trading, were at increased risk for HTLV-I infection (OR 1.9; CI 1.3-2.7) compared with other areas in Guadeloupe devoted to other activities. Our report of HTLV-I cluster identification in Guadeloupe probably reflects both its low spread and its highly intrafamilial restricted transmission within this endemic Caribbean population.
20
Bernard J. Poiesz, Francis W. Ruscetti, Adi F. Gazdar et al. · Proceedings of the National Academy of Sciences · 1980 · 5.1K citations · Full text
ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS
Antoine Gessain, J C Vernant, L. Maurs et al. · The Lancet · 1985 · 2.9K citations
Richard S. Garfein, David Vlahov, Noya Galai et al. · American Journal of Public Health · 1996 · 705 citations
Public Health, Infectious Disease Control, Drug Utilization Review +6